DISCOUNT OPTIONSSCHEIN - AMGEN | Market Closed - Börse Stuttgart 10:18:59 10/05/2024 pm IST | ||
| 1.2 EUR | +5.26% |
|
| Current month | +39.53% | ||
| 1 month | +14.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 1.2 | +5.26% | 0 |
| 09/24/09 | 1.14 | +9.62% | 0 |
| 08/24/08 | 1.04 | +5.05% | 0 |
| 07/24/07 | 0.99 | +3.13% | 0 |
| 06/24/06 | 0.96 | -47.25% | 0 |
Delayed Quote Börse Stuttgart
Last update May 10, 2024 at 10:18 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME22L0 |
| ISIN | DE000ME22L01 |
| Date issued | 13/10/2023 |
| Strike | 350 $ |
| Maturity | 21/06/2024 (40 Days) |
| Parity | 1 : 1 |
| Emission price | 2.08 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.67 € |
|---|---|
| Lowest since issue | 0.73 € |
| Spread | 0.09 € |
| Spread % | 7.56% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat